| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.033 | 0.9 |